Sophie Vieujean (Translational Gastroenterology, CHU, Liège GIGA-Research) 

Involvement of intestinal epithelium in fibrosis initiation and worsening in Crohn’s disease

Sophie Van Welden (U Gent)

Prolyl hydroxylase 1, a promising therapeutic target for colitis-associated cancer

Liselotte Fierens  (KU Leuven)

Quality of care for patients with Inflammatory bowel diseases



Kathleen Machiels and Clara Caenepeel (KU Leuven)

Predictive potential and role of microbiota in the efficacy of biological treatment and development of paradoxical adverse events in patients with inflammatory bowel disease

Ho-Su Lee (KU Leuven)

Familial aggregation in Inflammatory Bowel Disease: a next-generation sequencing study

Marie Truyens (U Gent)

The etiopathogenesis of persistent fatigue in patients with inflammatory bowel disease


Kaline Arnauts  (KU Leuven)

The effect of microbiota on intestinal epithelial cells in ulcerative colitis

Simon Bos (U Gent)

Early detection and longitudinal monitoring of intestinal fibrosis in patients with crohn’s disease

Lucas Wauters (KU Leuven)

Unravelling the small bowel microbiome in Crohn’s disease


Sare Verstockt   (KU Leuven)

Molecular profiling of early events in IBD pathogenesis to find markers for early diagnosis

Wiebe Van Hove / Magalie de Bruyn  (KU Leuven)                  

Primary intestinal epithelial cells: a personalized tool for functional characterization of IBD-associated pathways

Cara De Galan (U Gent)

Predictive factors for the clinical response to vedolizumab



Joao Sabino (Leuven)
Food influence on the Intestinal microbioTa trial (FIT trial)
Claire Liefferinckx (Bruxelles)
Identification of Genetic variants regulating gEne hubs in the cOntrol of specific and genericmodules across context-dependent activation of Immune Cells in healthy subjects: Understandingthe genetic architecture Of Disease sEverity in IBD (GEOCODE IBD project)
Bram Verstockt (Leuven)
Predicting outcome of inflammatory bowel diseases: creating opportunities for personalized medicine


Hindryckx Pieter  (UGent)
The contribution of hypoxia to the pathogenesis and the course of inflammatory bowel disease: defining the window for therapeutic intervention
Vancamelbeke Maaike (KU Leuven)
The Role of the Intestinal Epithelial Barrier in the Pathophysiology of Inflammatory Bowel Diseases


Ingrid Arijs (Leuven)
Study of the effect of vedolizumab therapy on colonic mucosal gene expression in patients with ulcerative colitis

Manuel Nobel (Leuven)
Intestinal stem cells - microbiota interactions in inflammatory bowel diseases


Debby Laukens (Gent)
The therapeutic use of anti-metallothionein antibodies in IBD: bench-to-bedside

Dominiek Staelens and Kris Nys (Leuven)
Crohn's susceptibility genes in innate immunity, ER stress and autophagy: from genetics to personalized medicine

2012 Marthe Heylen (Antwerpen)
The therapeutic potential of maintenance therapy with wormproteins in a chronic colitis model in mice: study of the underlying immunological mechanisms

COVID-19: Informations pour les patients MICI

Corona_version française (update 28 avril 2021)

Cher patient MICI,

Compte tenu des nombreuses questions qui se posent sur l'épidémie de et la vaccination contre couronne, vous pouvez cliquer sur MORE --> pour trouver des informations générales.

Ces informations sont ajustées à mesure que de nouveaux développements se produisent.


COVID-19: Informatie voor IBD patiënten

Corona_Nederlandstalige versie (update 28 April 2021)

Beste IBD patiënt,

Gezien de vele vragen die er rijzen naar aanleiding van de corona epidemie en de vaccinatie, kan u hier doorklikken op
MORE--> om algemene informatie terug te vinden.

Deze informatie wordt aangepast naarmate zich nieuwe ontwikkelingen voordoen.